Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults
Clinical trial NCT02008396 · COMPLETED
Trial details
- NCT number
- NCT02008396
- Sponsor
- Resilient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-11
- Primary completion
- 2017-04-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.